Distributed Multiple Testing with False Discovery Rate Control in the Presence of Byzantines
Daofu Zhang, Mehrdad Pournaderi, Yu Xiang, Pramod Varshney

TL;DR
This paper investigates how Byzantine attacks impact distributed multiple testing procedures controlling the false discovery rate, proposing analysis and countermeasures to maintain statistical integrity under adversarial conditions.
Contribution
It introduces a comprehensive analysis of Byzantine attack effects on FDR control in distributed testing and proposes strategies to mitigate these attacks.
Findings
Byzantine attacks can significantly inflate FDR in distributed testing.
Counter-attack strategies can effectively reduce the impact of Byzantine nodes.
Simulation results validate theoretical analysis and reveal trade-offs in attack and defense mechanisms.
Abstract
This work studies distributed multiple testing with false discovery rate (FDR) control in the presence of Byzantine attacks, where an adversary captures a fraction of the nodes and corrupts their reported p-values. We focus on two baseline attack models: an oracle model with the full knowledge of which hypotheses are true nulls, and a practical attack model that leverages the Benjamini-Hochberg (BH) procedure locally to classify which p-values follow the true null hypotheses. We provide a thorough characterization of how both attack models affect the global FDR, which in turn motivates counter-attack strategies and stronger attack models. Our extensive simulation studies confirm the theoretical results, highlight key design trade-offs under attacks and countermeasures, and provide insights into more sophisticated attacks.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAdvanced Statistical Process Monitoring · Statistical Methods in Clinical Trials
MethodsFocus
